Tissue-based Chimerism Analysis Enhances Detection of Donor-derived Neoplasia in Allogeneic Stem Cell Transplant Patients

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2016 Dec 20

PMID 27991892

Authors

E G Baraban

S Hu

P Hui

N Podoltsev

D Cooper

M L Xu

Affiliations

Soon will be listed here.

References

Rodriguez-Macias G, Martinez-Laperche C, Gayoso J, Noriega V, Serrano D, Balsalobre P . Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia. Hum Pathol. 2013; 44(8):1696-9. DOI: 10.1016/j.humpath.2013.01.001. View

Genovese G, Kahler A, Handsaker R, Lindberg J, Rose S, Bakhoum S . Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371(26):2477-87. PMC: 4290021. DOI: 10.1056/NEJMoa1409405. View

Reichard K, Zhang Q, Sanchez L, Hozier J, Viswanatha D, Foucar K . Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature. Am J Hematol. 2006; 81(3):178-85. DOI: 10.1002/ajh.20389. View

Steensma D, Bejar R, Jaiswal S, Lindsley R, Sekeres M, Hasserjian R . Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015; 126(1):9-16. PMC: 4624443. DOI: 10.1182/blood-2015-03-631747. View

Jacobs K, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B . Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012; 44(6):651-8. PMC: 3372921. DOI: 10.1038/ng.2270. View

Gondek L, Zheng G, Ghiaur G, DeZern A, Matsui W, Yegnasubramanian S . Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia. 2016; 30(9):1916-1920. PMC: 5014666. DOI: 10.1038/leu.2016.63. View

Laurie C, Laurie C, Rice K, Doheny K, Zelnick L, McHugh C . Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet. 2012; 44(6):642-50. PMC: 3366033. DOI: 10.1038/ng.2271. View

Fialkow P, Thomas E, Bryant J, Neiman P . Leukaemic transformation of engrafted human marrow cells in vivo. Lancet. 1971; 1(7693):251-5. DOI: 10.1016/s0140-6736(71)90998-6. View

Daly A, Kamel-Reid S, Lipton J, Messner H, Kiss T, Chun K . Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia. Leuk Res. 2004; 28(10):1107-11. DOI: 10.1016/j.leukres.2004.02.003. View

10.

Kurosawa S, Doki N, Hino Y, Sakaguchi M, Fukushima K, Shingai N . Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia. Intern Med. 2016; 55(4):395-7. DOI: 10.2169/internalmedicine.55.5400. View

11.

Deol A, Lum L . Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited. Cancer Treat Rev. 2010; 36(7):528-38. PMC: 2921454. DOI: 10.1016/j.ctrv.2010.03.004. View

12.

Cutting R, Welch E, Channer J, Ezaydi Y, Talley P, Reilly J . Myelofibrosis as the initial presentation of donor-derived myelodysplastic syndrome/AML: failure of a lasting response to a second allogeneic transplant from the original donor. Bone Marrow Transplant. 2008; 42(9):631-3. DOI: 10.1038/bmt.2008.224. View

13.

Wang E, Hutchinson C, Huang Q, Lu C, Crow J, Wang F . Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature. Am J Clin Pathol. 2011; 135(4):525-40. DOI: 10.1309/AJCPPJUQ9DNR1GHP. View

14.

Shiozaki H, Yoshinaga K, Kondo T, Imai Y, Shiseki M, Mori N . Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source. Bone Marrow Transplant. 2013; 49(1):102-9. DOI: 10.1038/bmt.2013.127. View

15.

Kato M, Yamashita T, Suzuki R, Matsumoto K, Nishimori H, Takahashi S . Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation. Leukemia. 2016; 30(8):1742-5. DOI: 10.1038/leu.2016.23. View

16.

Xiao H, Shi J, Luo Y, Tan Y, He J, Xie W . First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2011; 117(19):5257-60. DOI: 10.1182/blood-2010-12-326322. View

17.

Ruiz-Delgado G, Hernandez-Reyes J, Gonzalez-Ramirez M, Martagon-Herrera N, Garces-Eisele J, Ruiz-Arguelles A . [Donor cell leukemia (DCL): A prospective study of its identification and treatment]. Gac Med Mex. 2015; 151(5):582-7. View

18.

Hayes C, Petersen B, Malone A . Donor Cell Myeloid Sarcoma in an Umbilical Cord Transplant Patient: A Case Report and a Review of the Literature. Case Rep Hematol. 2016; 2015:186869. PMC: 4707376. DOI: 10.1155/2015/186869. View

19.

Luznik L, ODonnell P, Symons H, Chen A, Leffell M, Zahurak M . HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008; 14(6):641-50. PMC: 2633246. DOI: 10.1016/j.bbmt.2008.03.005. View

20.

Bobadilla-Morales L, Pimentel-Gutierrez H, Gallegos-Castorena S, Paniagua-Padilla J, Ortega-de-la-Torre C, Sanchez-Zubieta F . Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor. Mol Cytogenet. 2015; 8:5. PMC: 4324859. DOI: 10.1186/s13039-014-0105-4. View